title: Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome.
abstract: The aim of this analysis was to assess the predictive value of activated factor XII type A (XIIaA) and B-type natriuretic peptide (BNP) in acute coronary syndrome patients stratified according to troponin release and to evaluate their complementary utility as predictors of all-cause mortality and recurrent troponin T (TnT)-positive events. Multivariable analysis in 870 patients admitted with suspected myocardial infarction was performed using the Cox proportional hazard ratio model. Variables in the model included XIIaA and BNP as well as conventional risk factors for mortality. Although both XIIaA and BNP were identified as independent predictors for all-cause mortality in the total group of patients, only BNP was found to be an independent predictor for all-cause mortality in patients with a confirmed myocardial infarction (TnT > 0.05 ng/ml) at admission (hazard ratio 4.24, 95% confidence interval 1.28-14.07), whereas only XIIaA was an independent predictor for all-cause mortality in patients with low TnT release (0.01 < TnT < or = 0.05 ng/ml) at admission (hazard ratio 10.37, 95% confidence interval 2.89-37.21). The combination of these two biomarkers provided complementary prognostic information for all-cause mortality as compared with each of the biomarkers alone in the total patient material. XIIaA is particularly useful in predicting mortality in acute coronary syndrome patients with low troponin release, whereas BNP is effective in predicting mortality in patients with confirmed myocardial infarction and more substantial troponin release. The combination of these two biomarkers improves outcome prediction in unselected patients with chest pain and acute coronary syndrome.
authors.affiliation: Institute of Medicine, University of Bergen, Bergen, Norway. volker.poenitz@lyse.net
authors.forename: Volker
authors.initials: V
authors.lastname: Pönitz
authors.forename: Trygve
authors.initials: T
authors.lastname: Brügger-Andersen
authors.forename: David
authors.initials: D
authors.lastname: Pritchard
authors.forename: Heidi
authors.initials: H
authors.lastname: Grundt
authors.forename: Harry
authors.initials: H
authors.lastname: Staines
authors.forename: Dennis W T
authors.initials: DW
authors.lastname: Nilsen
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000401:mortality*; D015415:Biomarkers / Q000097:blood; D015956:Factor XIIa / Q000032:analysis*; D009026:Mortality; D015999:Multivariate Analysis; D009203:Myocardial Infarction; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D020107:Troponin T
chemical_list: D015415:Biomarkers; D020107:Troponin T; D020097:Natriuretic Peptide, Brain; D015956:Factor XIIa